MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization

MLA

Chad J. Fleming, et al. “MELD-Na > 16 Is Associated with High Peri-Procedural and Short-Term Mortality in Patients with Ruptured Hepatocellular Carcinoma Treated with Emergent Transarterial Embolization.” Abdominal Radiology, vol. 47, Oct. 2021, pp. 416–22. EBSCOhost, https://doi.org/10.1007/s00261-021-03306-2.

APA

Chad J. Fleming, James C. Andrews, Scott M. Thompson, Andrew H. Stockland, Michael C. Jundt, & Robert L. Owen. (2021). MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization. Abdominal Radiology, 47, 416–422. https://doi.org/10.1007/s00261-021-03306-2

Chicago

Chad J. Fleming, James C. Andrews, Scott M. Thompson, Andrew H. Stockland, Michael C. Jundt, and Robert L. Owen. 2021. “MELD-Na > 16 Is Associated with High Peri-Procedural and Short-Term Mortality in Patients with Ruptured Hepatocellular Carcinoma Treated with Emergent Transarterial Embolization.” Abdominal Radiology 47 (October): 416–22. doi:10.1007/s00261-021-03306-2.